## India Achieves Kala-Azar Elimination Target
India has successfully achieved its target of eliminating visceral leishmaniasis, commonly known as kala-azar, according to data from the National Centre for Vector Borne Diseases Control (NCVBDC). This significant milestone comes after years of dedicated efforts by the government and healthcare workers.
A Long-Standing Challenge
Kala-azar, a vector-borne disease transmitted by sandflies, has posed a significant health challenge for decades, particularly in states like Bihar, Jharkhand, West Bengal, and Uttar Pradesh. The initial target for elimination was set for 2010, but due to persistent challenges, it was extended to 2023.
Meeting the Elimination Criteria
The latest data from NCVBDC indicates that India reported only 520 cases of kala-azar in 2023 across the entire country. This meets the elimination criteria set by the World Health Organization (WHO), which defines elimination as no block in the country reporting more than one case per 10,000 people.
Key Interventions for Success
Indoor spraying to kill sandflies
Sealing potential breeding sites
Mobilizing healthcare workers to ensure proper treatment completion
These interventions have effectively reduced the transmission of the disease and prevented new cases.
Challenges and the Path Forward
While India has achieved the target for kala-azar elimination, challenges remain, particularly in states like Bihar and Jharkhand, where cases of post-kala-azar dermal leishmaniasis (PKDL) are still relatively high. Public health experts emphasize the importance of continued surveillance, robust healthcare infrastructure, and community engagement to prevent the resurgence of kala-azar and other vector-borne diseases.
Sustaining Progress and Achieving Kala-Azar-Free Status
India's achievement in eliminating kala-azar is a significant step towards improving public health outcomes. However, sustaining this progress is crucial for the country to be declared kala-azar-free by the WHO. This will require continued efforts to strengthen healthcare systems, improve access to diagnosis and treatment, and maintain vigilance against the resurgence of the disease.